Pictet Asset Management Holding SA Cuts Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Pictet Asset Management Holding SA decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 989,600 shares of the medical equipment provider’s stock after selling 17,412 shares during the quarter. Pictet Asset Management Holding SA owned about 0.28% of Intuitive Surgical worth $516,532,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of the business. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $25,000. Berbice Capital Management LLC bought a new stake in Intuitive Surgical during the fourth quarter worth approximately $26,000. BankPlus Trust Department purchased a new stake in Intuitive Surgical during the fourth quarter valued at approximately $28,000. Kohmann Bosshard Financial Services LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $31,000. Finally, Decker Retirement Planning Inc. purchased a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $36,000. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Myriam Curet sold 408 shares of the business’s stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the transaction, the executive vice president now directly owns 353 shares in the company, valued at approximately $208,181.75. The trade was a 53.61 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock valued at $17,691,621 over the last 90 days. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $507.90 on Friday. The firm has a 50-day simple moving average of $558.29 and a 200-day simple moving average of $532.25. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The firm has a market cap of $180.90 billion, a P/E ratio of 79.24, a P/E/G ratio of 5.85 and a beta of 1.43.

Analysts Set New Price Targets

Several research firms recently weighed in on ISRG. Robert W. Baird lowered their price target on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a research report on Tuesday, March 18th. Jefferies Financial Group increased their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Erste Group Bank cut shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 17th. Barclays increased their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Finally, Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.